Fulgent Genetics Inc. (FLGT)
17.58
0.45 (2.63%)
At close: Jan 15, 2025, 9:48 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY01 |
| Net Income | -167.82M | 141.92M | 506.24M | 214.31M | -411.00K | -5.61M | -2.51M | -5.39M | -4.99M | -990.00K | 507.36M |
| Depreciation & Amortization | 26.14M | 32.66M | 11.00M | 2.96M | 2.11M | 2.16M | 1.73M | 1.17M | 575.00K | 196.00K | 11.00M |
| Stock-Based Compensation | 42.92M | 32.64M | 15.88M | 8.16M | 3.21M | 2.30M | 2.12M | 4.65M | 8.16M | n/a | 15.88M |
| Other Working Capital | 7.35M | -41.29M | -32.77M | 64.41M | 253.00K | 36.80M | 29.93M | 22.82M | 2.24M | 274.00K | n/a |
| Other Non-Cash Items | 115.31M | 43.46M | 15.97M | 8.05M | 1.55M | 1.67M | 1.04M | 5.58M | 362.00K | -3.28M | -534.25M |
| Deferred Income Tax | 7.61M | 831.00K | -7.84M | -1.40M | -21.00K | 36.00K | -336.00K | 246.00K | -3.33M | n/a | n/a |
| Change in Working Capital | 2.84M | 2.00M | -2.68M | -91.45M | -915.00K | -1.24M | -714.00K | -1.86M | -1.75M | -323.00K | n/a |
| Operating Cash Flow | 27.00M | 253.52M | 538.58M | 140.63M | 5.52M | -675.00K | 1.33M | 4.41M | -969.00K | -4.40M | 534.25M |
| Capital Expenditures | -22.21M | -18.77M | -23.84M | -36.51M | -1.32M | -2.83M | -5.36M | -3.79M | -2.10M | -731.00K | n/a |
| Acquisitions | -399.00K | -182.68M | -61.87M | -2.59M | 137.00K | 510.00K | 2.46M | 10.00K | 3.57M | n/a | n/a |
| Purchase of Investments | -491.91M | -432.98M | -730.49M | -324.36M | -52.08M | -24.19M | -11.66M | -39.02M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 552.64M | 372.71M | 269.59M | 37.01M | 24.35M | 27.97M | 14.97M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 775.00K | 412.00K | 63.00K | 8.00K | -137.00K | -510.00K | -2.46M | 10.00K | -105.00K | -49.00K | n/a |
| Investing Cash Flow | 38.90M | -261.31M | -546.55M | -326.44M | -29.05M | 950.00K | -2.05M | -42.80M | -2.21M | -780.00K | n/a |
| Debt Repayment | -5.00M | -1.07M | -11.00K | 15.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | -27.79M | -76.11M | -4.16M | -62.00K | -21.00K | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.59M | n/a | n/a | n/a |
| Other Financial Acitivies | -15.00M | 31.00K | 96.00K | 104.00K | 17.00K | 15.00K | -770.00K | 13.59M | 3.50M | 4.00M | n/a |
| Financial Cash Flow | -47.78M | -77.14M | 85.39M | 261.25M | 28.77M | 15.00K | -770.00K | 45.79M | 3.50M | 4.00M | n/a |
| Net Cash Flow | 17.97M | -85.39M | 77.47M | 75.46M | 5.23M | 246.00K | -1.41M | 7.40M | 326.00K | -1.18M | 534.25M |
| Free Cash Flow | 4.80M | 234.75M | 514.73M | 104.12M | 4.20M | -3.51M | -4.03M | 617.00K | -3.07M | -5.13M | 534.25M |